The medical and pharmaceutical fields are rapidly evolving, driven by scientific discoveries and clinical innovations. In 2025, global academic platforms are actively accepting submissions through open Calls for Papers (CFPs) in the domains of Medical Science and Pharmacy. Researchers, practitioners, and scholars are encouraged to submit original work to contribute to the advancement of healthcare systems and pharmaceutical knowledge.
Medical and Pharmacy conferences in 2025 invite papers in a wide range of specialties, including but not limited to:
Pharmacology and Drug Development
Clinical Trials and Therapeutics
Public Health and Epidemiology
Biomedical Engineering and Diagnostics
Pharmacy Practice and Policy
Molecular Medicine and Genomics
Health Informatics and E-Health
Regulatory Affairs and Safety Monitoring
These fields represent the forefront of medical innovation and provide meaningful platforms for showcasing new approaches, therapies, and evidence-based practices.
Publishing in peer-reviewed medical or pharmaceutical venues offers researchers:
International visibility for new research findings
Opportunities to collaborate across disciplines
Academic recognition and citation potential
Input from leading experts through peer review
Compliance with university or grant publication requirements
Leading CFP aggregators such as iConf.org make it easier for scholars to identify suitable conferences across various medical subdomains.
Submissions typically include:
Full papers with data analysis
Abstracts or case reports
Review articles or meta-analyses
All entries are evaluated by qualified reviewers in a blind review process to ensure scientific rigor, originality, and relevance. Authors are encouraged to follow detailed formatting instructions and submission deadlines provided by the respective events.
Whether your work focuses on developing new pharmaceutical compounds, improving healthcare delivery, or innovating in diagnostics, now is the time to publish. Explore active calls for papers in Medical and Pharmacy and contribute to a healthier, evidence-driven future.